Download Cumulative Subject Index, Volumes 31, 32 and 34-60 by Nathan P. Kaplan, Nathan P. Colowick, Martha G. Dennis, PDF

By Nathan P. Kaplan, Nathan P. Colowick, Martha G. Dennis, Edward A. Dennis

The severely acclaimed laboratory commonplace, Methods in Enzymology, is likely one of the so much hugely revered courses within the box of biochemistry. considering the fact that 1955, each one quantity has been eagerly awaited, usually consulted, and praised by means of researchers and reviewers alike. The sequence includes a lot fabric nonetheless appropriate this present day - actually a vital e-book for researchers in all fields of existence sciences

Show description

Read or Download Cumulative Subject Index, Volumes 31, 32 and 34-60 PDF

Best molecular biology books

Gene Cloning

Studying this ebook as an intro to the area of PCR and a venture entailing site-directed mutagenesis was once super useful from every little thing from establishing a PCR cycle and what plasmids are higher for cloning or expression to info of a change and protein expression innovations. total, a great booklet to have within the lab!

Advanced Molecular Biology: A Concise Reference

Complicated Molecular Biology emphasises the unifying rules and mechanisms of molecular biology, with common use of tables and packing containers to summarise experimental info and gene and protein capabilities. broad cross-referencing among chapters is used to enhance and expand the certainty of center ideas.

Kinetics of Enzyme-Modifier Interactions: Selected Topics in the Theory and Diagnosis of Inhibition and Activation Mechanisms

The kinetic mechanisms wherein enzymes have interaction with inhibitors and activators, jointly known as modifiers, are scrutinized and ranked taxonomically into self reliant species in a fashion just like that utilized in the organic type of vegetation and animals. The systematization of the mechanisms is predicated on primary characters: the allosteric linkage among substrate and modifier and the issue through which a modifier impacts the catalytic consistent of the enzyme.

Advances in Microbial Systems Biology

Advances in Microbial body structure is without doubt one of the so much profitable and prestigious sequence from educational Press, an imprint of Elsevier. It publishes topical and critical experiences, reading body structure to incorporate all fabric that contributes to our realizing of ways microorganisms and their part components paintings.

Extra resources for Cumulative Subject Index, Volumes 31, 32 and 34-60

Sample text

F~ activity, assay, LV, 365 uncouplers, LV, 463 venturicidin, LV, 505, 506 in yeast, measurement, XXXII, 842, 843 Adenosinetriphosphatase F1 antibodies, LVI, 227 2-azido-4-nitrophenol labeled, LVI, 677-680 :mutants, LVI, 115 immunological assay, LV, 802 subunits, LVI, 596-602 assay, LV, 320, 324, 325 functions, LV, 297 from N . F1, reconstitution, LVI, 600, 601 Adenosine 5'-triphosphate, XXXIV, 135, 258, 259, 486 activator of aspartate transcarbamoylase, LI, 35 of ribonucleoside diphosphate reductase, LI, 238, 245 active transport, XLIV, 921-924 ADP exchange reaction, XXXV, 31 amidophosphoribosyltransferase assay, LI, 172 aminoacylation of tRNA, LIX, 126-128, 130, 132, 133, 183, 216, 221, 231, 288, 298, 818 p-aminophenyl ester, XXXIV, 255, 259, 260 analog, XXXIV, 4; XLVI, 241, 259, 295, 302 characterization, XLIV, 868, 869 coenzymic activity, XLIV, 873-876 immobilization, XLIV, 869-873 inhibitors of tryptophanyl-tRNA synthetase, LIX, 254-256 synthesis, XLIV, 866-868 aqueous stock solution, stability, LVII, 38 26 assay, LV, 221 of adenosine monophosphate nucleosidase, LI, 264 of bacterial count, LVII, 70 comparative sensitivity of commercial enzyme preparations, LVII, 554, 555 continuous, LVII, 36-50 of creatine kinase isoenzymes, LVII, 61 of cyclic nucleotide phosphodiesterases, LVII, 97 effect of arsenate, LVII, 13, 14 with firefly luciferase, procedure, LVII, 11, 77, 556 internal light-color control, LVII, 3 of luciferase, LVII, 30 in mitochondria, LVII, 37-49 principle, LVII, 37 procedure, LVII, 39-49 of pyrimidine nucleosidase monophosphate kinase, LI, 322, 323 of ribonucleoside triphosphate reductase, LI, 247-250 sensitivity, LVII, 83, 84 sources of error, LVII, 5, 29, 83, 93 of tryptophanyl-tRNA synthetase, LIX, 237, 238 brown adipose tissue mitochondria, LV, 74, 77, 78 calcium transport, LVI, 238, 239, 338 cAMP assay, XXXVIII, 56 cell-free protein synthesis system, LIX, 300, 448, 459, 850 cellular level, drug metabolism, LII, 66, 69 chromatographic mobility, LIX, 73 chromatographic separation, LI, 459, 460 CoA-binding protein, XXXIV, 270 Co(III) complex, XLVI, 313, 314, 318 codon-anticodon recognition studies, LIX, 296 concentration rapid kinetics, LVI, 540, 541 rate of change, LVI, 537-540 relationship to biomass, LVII, 84, 85 27 concentration curves, comparative, for evaluation of photometers, LVII, 558 content per average bacterium, LVII, 66 of brain, LV, 218 of hepatocytes, LV, 214 of kidney cortex, LV, 220 of rat heart, LV, 216, 217 of rat liver, LV, 213 Co(III)-phen complex, XI,VI, 314, 315, 318-321 coupling factor, LV, 192 cyanine fluorescence, LV, 579 cyanylation, XLVII, 131 cyclase assay, XXXVIII, 131, 141, 146 cyclic nucleotide immunoassay, XXXVIII, 102, 103 determination of aminoacylation isomeric specificity, LIX, 272 disodium salt self-association, XLVIII, 116 storage, LI, 338 effect of vacuum filtration, LVII, 80 effiux kinetic studies, LVI, 259 enzymic conversion to ADP, LVII, 89 estimation, XXXVII, 248 exchange, LVI, 253 exchange reactions, LV, 253, 254 measurement, LV, 258 extraction from bacteria, LVII, 68 in fat cells, proteolytic enzyme effects, XXXVII, 213 fluorescence, LVI, 499, 500 formation from cAMP, XXXVIII, 62 in hexokinase assay, XLIV, 342, 455, 457, 476 hydrogen ion extrusion, LV, 227 hydrolysis during work-up, LV, 238 immobilization, on Sepharose, XLIV, 882 inhibitor of adenylate deaminase, LI, 496 of amidophosphoribosyltransferase, LI, 178 of aspartate carbamyltransferase, LI, 57 of orotate phosphoribosyltransferase, LI, 163 Adenosine 5'-triphosphate of orotidylate decarboxylase, LI, 163 of tryptophanyl-tRNA synthetase, LIX, 252 initial rate of synthesis artificial electrochemical proton gradient, LVI, 494--495 respiration, LVI, 496 internal standard solution, LVII, 55, 61, 70, 75 application, LVII, 64, 77, 78, 83 intramitochondrial, phosphorylation potential, LV, 241, 242 in isolated renal tubules, XXXIX, 16, 18 labeled chromatography, XXXVIII, 67, 68 determination of activity, LX, 513-516 impurities, XXXVIII, 45, 46 preparation, XXXVIII, 107, 108; LX, 497, 512, 513 use in lysate phosphoprotein synthesis, LX, 511-516 in protein kinase assay, LX, 499 level, in kidney perfusion, XXXIX, 10 as ligand, XXXIV, 482 luciferase assay, LIII, 559 in media, LVIII, 66 Mg2÷-activated, in preparation of chromophore labeled sarcoplasmic reticulum vesicles, LIV, 51 misactivation studies, LIX, 286 mitochondrial, XXXIV, 566-571 mitochondrial protein synthesis, LVI, 21, 22 Na+,K+-activated, XXXIV, 4 1sO content, reactions contributing, LV, 256 onset of labeling during synthesis by chloroplasts procedure, LV, 247 reagents, LV, 246, 247 Pasteur effect, LV, 291 perchlorate, LV, 202 in perfused hemicorpus, XXXIX, 80-82 P1 exchange reaction, XXXV, 31 Adenosine 5'-triphosphate phosphate donor, of adenylate kinase, LI, 459 of deoxycytidine kinase, LI, 337 of deoxythymidine kinase, LI, 360, 361, 364 of guanylate kinase, LI, 473,483, 489 of Lactobacillus deoxynucleoside kinases, LI, 346 of nucleoside diphosphokinase, LI, 377 of pyrimidine nucleoside monophosphate kinase, LI, 321 of thymidine kinase, LI, 355, 358, 365, 370 of uridylate-cytidylate kinase, LI, 331,332, 336 phosphodiesterase, XXXVIII, 154, 155, 233, 248 phosphofructokinase, XXXVIII, 397, 398 photochemically active derivatives, LVI, 656 potassium salt, dissociation constant, LV, 237 preparation of 3'-amino-3'-deoxyATP, LIX, 135 of E.

F1, reconstitution, LVI, 600, 601 Adenosine 5'-triphosphate, XXXIV, 135, 258, 259, 486 activator of aspartate transcarbamoylase, LI, 35 of ribonucleoside diphosphate reductase, LI, 238, 245 active transport, XLIV, 921-924 ADP exchange reaction, XXXV, 31 amidophosphoribosyltransferase assay, LI, 172 aminoacylation of tRNA, LIX, 126-128, 130, 132, 133, 183, 216, 221, 231, 288, 298, 818 p-aminophenyl ester, XXXIV, 255, 259, 260 analog, XXXIV, 4; XLVI, 241, 259, 295, 302 characterization, XLIV, 868, 869 coenzymic activity, XLIV, 873-876 immobilization, XLIV, 869-873 inhibitors of tryptophanyl-tRNA synthetase, LIX, 254-256 synthesis, XLIV, 866-868 aqueous stock solution, stability, LVII, 38 26 assay, LV, 221 of adenosine monophosphate nucleosidase, LI, 264 of bacterial count, LVII, 70 comparative sensitivity of commercial enzyme preparations, LVII, 554, 555 continuous, LVII, 36-50 of creatine kinase isoenzymes, LVII, 61 of cyclic nucleotide phosphodiesterases, LVII, 97 effect of arsenate, LVII, 13, 14 with firefly luciferase, procedure, LVII, 11, 77, 556 internal light-color control, LVII, 3 of luciferase, LVII, 30 in mitochondria, LVII, 37-49 principle, LVII, 37 procedure, LVII, 39-49 of pyrimidine nucleosidase monophosphate kinase, LI, 322, 323 of ribonucleoside triphosphate reductase, LI, 247-250 sensitivity, LVII, 83, 84 sources of error, LVII, 5, 29, 83, 93 of tryptophanyl-tRNA synthetase, LIX, 237, 238 brown adipose tissue mitochondria, LV, 74, 77, 78 calcium transport, LVI, 238, 239, 338 cAMP assay, XXXVIII, 56 cell-free protein synthesis system, LIX, 300, 448, 459, 850 cellular level, drug metabolism, LII, 66, 69 chromatographic mobility, LIX, 73 chromatographic separation, LI, 459, 460 CoA-binding protein, XXXIV, 270 Co(III) complex, XLVI, 313, 314, 318 codon-anticodon recognition studies, LIX, 296 concentration rapid kinetics, LVI, 540, 541 rate of change, LVI, 537-540 relationship to biomass, LVII, 84, 85 27 concentration curves, comparative, for evaluation of photometers, LVII, 558 content per average bacterium, LVII, 66 of brain, LV, 218 of hepatocytes, LV, 214 of kidney cortex, LV, 220 of rat heart, LV, 216, 217 of rat liver, LV, 213 Co(III)-phen complex, XI,VI, 314, 315, 318-321 coupling factor, LV, 192 cyanine fluorescence, LV, 579 cyanylation, XLVII, 131 cyclase assay, XXXVIII, 131, 141, 146 cyclic nucleotide immunoassay, XXXVIII, 102, 103 determination of aminoacylation isomeric specificity, LIX, 272 disodium salt self-association, XLVIII, 116 storage, LI, 338 effect of vacuum filtration, LVII, 80 effiux kinetic studies, LVI, 259 enzymic conversion to ADP, LVII, 89 estimation, XXXVII, 248 exchange, LVI, 253 exchange reactions, LV, 253, 254 measurement, LV, 258 extraction from bacteria, LVII, 68 in fat cells, proteolytic enzyme effects, XXXVII, 213 fluorescence, LVI, 499, 500 formation from cAMP, XXXVIII, 62 in hexokinase assay, XLIV, 342, 455, 457, 476 hydrogen ion extrusion, LV, 227 hydrolysis during work-up, LV, 238 immobilization, on Sepharose, XLIV, 882 inhibitor of adenylate deaminase, LI, 496 of amidophosphoribosyltransferase, LI, 178 of aspartate carbamyltransferase, LI, 57 of orotate phosphoribosyltransferase, LI, 163 Adenosine 5'-triphosphate of orotidylate decarboxylase, LI, 163 of tryptophanyl-tRNA synthetase, LIX, 252 initial rate of synthesis artificial electrochemical proton gradient, LVI, 494--495 respiration, LVI, 496 internal standard solution, LVII, 55, 61, 70, 75 application, LVII, 64, 77, 78, 83 intramitochondrial, phosphorylation potential, LV, 241, 242 in isolated renal tubules, XXXIX, 16, 18 labeled chromatography, XXXVIII, 67, 68 determination of activity, LX, 513-516 impurities, XXXVIII, 45, 46 preparation, XXXVIII, 107, 108; LX, 497, 512, 513 use in lysate phosphoprotein synthesis, LX, 511-516 in protein kinase assay, LX, 499 level, in kidney perfusion, XXXIX, 10 as ligand, XXXIV, 482 luciferase assay, LIII, 559 in media, LVIII, 66 Mg2÷-activated, in preparation of chromophore labeled sarcoplasmic reticulum vesicles, LIV, 51 misactivation studies, LIX, 286 mitochondrial, XXXIV, 566-571 mitochondrial protein synthesis, LVI, 21, 22 Na+,K+-activated, XXXIV, 4 1sO content, reactions contributing, LV, 256 onset of labeling during synthesis by chloroplasts procedure, LV, 247 reagents, LV, 246, 247 Pasteur effect, LV, 291 perchlorate, LV, 202 in perfused hemicorpus, XXXIX, 80-82 P1 exchange reaction, XXXV, 31 Adenosine 5'-triphosphate phosphate donor, of adenylate kinase, LI, 459 of deoxycytidine kinase, LI, 337 of deoxythymidine kinase, LI, 360, 361, 364 of guanylate kinase, LI, 473,483, 489 of Lactobacillus deoxynucleoside kinases, LI, 346 of nucleoside diphosphokinase, LI, 377 of pyrimidine nucleoside monophosphate kinase, LI, 321 of thymidine kinase, LI, 355, 358, 365, 370 of uridylate-cytidylate kinase, LI, 331,332, 336 phosphodiesterase, XXXVIII, 154, 155, 233, 248 phosphofructokinase, XXXVIII, 397, 398 photochemically active derivatives, LVI, 656 potassium salt, dissociation constant, LV, 237 preparation of 3'-amino-3'-deoxyATP, LIX, 135 of E.

Coli, LI, 508-512 friction ratio, LI, 505 6-halopurine ribosides as substrates, XLVI, 328 from human erythrocytes, LI, 502-507 inactivation kinetics, XLVI, 334 inhibitors, LI, 506, 507, 511 kinetic properties, LI, 506, 511 molecular weight, LI, 505, 512 in nucleotidase assay, XXXII, 127, 369 partial specific volume, LI, 505 Adenosine deaminase properties, LI, 505, 506, 511, 512 purification, LI, 503-505, 509-511 purity, LI, 511 reaction, XLVI, 332, 333 sedimentation coefficient, LI, 505 stability, LI, 505, 512 Stokes radius, LI, 505 substrate specificity, LI, 505-507, 511 subunit structure, LI, 505 Adenosinediphosphatase, in plasma membranes, XXXI, 88 Adenosine 5'-diphosphate, XXXIV, 486; XLIV, 507; XLVI, 64, 65 acceptor control ratios, LVI, 687 activator, of adenylate deaminase, LI, 496 allosteric effector, of glutamate dehydrogenase, XLIV, 507, 512, 513 analogs, XLVI, 241 aqueous stock solution, stability, LVII, 38 assay, LV, 221; LVII, 74 of creatine kinase isoenzymes, LVII, 60, 63 of mitochondrial ATP production, LVII, 4 1 4 4 of photophosphorylation, LVII, 55 of succino-AICAR synthetase, LI, 187 binding proteins, XLVI, 248, 249 bound, phosphorylation, LVI, 496 cGMP assay, XXXVIII, 112 chloroplast ATPase, LV, 300 chromatographic separation, LI, 459, 460 CoA-binding protein, XXXIV, 270 Co(III) complex, XLVI, 313 content of brain, LV, 218 of hepatocytes, LV, 214 of kidney cortex, LV, 220 of rat heart, LV, 216, 217 of rat liver, LV, 213 coupling factor, LV, 189, 190, 192 E.

Download PDF sample

Rated 4.58 of 5 – based on 10 votes